Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × Polyps × Clear all

Phase

Phase NA 3 Phase 3 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 103 Carcinoma, Non-Small-Cell Lung 84 Prostatic Neoplasms 52 Colorectal Neoplasms 46 Nasopharyngeal Carcinoma 42 Neoplasms 38 Stomach Neoplasms 31 Multiple Myeloma 30 Lung Neoplasms 26 Neoplasm Metastasis 24 Carcinoma, Hepatocellular 24 Leukemia, Myeloid, Acute 23 Recurrence 22 Ovarian Neoplasms 21 Rectal Neoplasms 20 Uterine Cervical Neoplasms 19 Esophageal Neoplasms 19 Brain Neoplasms 19 Triple Negative Breast Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 18 Pancreatic Neoplasms 18 Small Cell Lung Carcinoma 17 Colonic Neoplasms 16 Urinary Bladder Neoplasms 14 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma, Follicular 14 Endometrial Neoplasms 13 Esophageal Squamous Cell Carcinoma 12 Carcinoma, Renal Cell 12 Myasthenia Gravis 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06950385 2026-03-17

SERENTA

Rapamycin Holdings Inc.

Phase 3 Recruiting

Gastrointestinal

Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡